2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Courageous Studios
Category
Video, Commercial & Film - Documentary
Country / Region
United States
Entrant Company
Min Jin Kook
Category
Interior Design - Interior Design / Others__
Country / Region
United States
Entrant Company
SFC Group
Category
Marketing Campaign - Integrated Marketing Campaign
Country / Region
United States
Entrant Company
AML Communications Limited
Category
Video, Commercial & Film - TV Commercial
Country / Region
United Kingdom